菲律宾批准新型禽流感疫苗商业化使用

Core Viewpoint - The Philippines has approved the commercial use of its first avian influenza vaccine, Volvac B.E.S.T. AI plus ND, which is expected to enhance the country's poultry industry production capacity [1] Group 1: Vaccine Approval - The Philippines' Food and Drug Administration (FDA) has recently approved the commercial use of the avian influenza vaccine [1] - The vaccine is applicable for poultry over 10 days old and provides complete immunity within 10 to 14 days post-vaccination [1] Group 2: Economic Impact - The approval of the vaccine is anticipated to strengthen the production capabilities of the poultry industry in the Philippines [1] - According to the National Statistics Office of the Philippines, the total output value of poultry, including eggs, is projected to reach 362 billion pesos (approximately 6.336 billion USD) in 2024 [1]